Items Tagged with 'Alzheimerâs disease'
On January 17, 2012, Medivation, Inc.(NASDAQ: MDVN) and Pfizer Inc. (NYSE: PFE) announced results from the CONCERT trial, which is a Phase 3 trial that evaluated dimebon (latrepirdine) when added to ongoing treatment with donepezil HCL tablets in patients with mild-to-moderate Alzheimer’s disease.
Profit from The Turnaround Letter's...
Market-Beating Investment Results
28+ Years of Turnaround Experience
Diverse Stock Picks for Today's Unpredictable Market
Distressed Investing Blog
These contrarian stock picks represent a diverse group of companies that have been among the worst performers in the Russell 2000 over the past year or so, trade reasonably actively and have decent businesses with good long term investing turnaround potential.
Free Stock Report
Put George Putnam's 28+ years of market-beating, contrarian investing advice to work for you, and give your portfolio a boost with this FREE stock report.
Current Total Returns
Total returns cover the fulll year 2013.
Note: Returns are not adjusted for inflation.
Copyright © All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing.